The presence of anti-HBs is generally interpreted as indicating recovery and immunity from hepatitis B virus infection.
Anti-HBs also develops in a person who has been successfully vaccinated against hepatitis B. Among vaccine responders who completed a vaccine series, anti-HBs levels can decline over time, however the majority are still immune and will mount a response when exposed to HBV.
< 10 mIU/mL is considered nonreactive for antibodies agains Hepatitis B surface antigen.
>= 10 mIU/mL is considered reactive for antibodies against Heptitis B surface antigen
Presence of antibody to hepatitis B surface antigen (anti-HBs) is used to determine immune status to HBV or disease progression in individuals infected with HBV. Anti-HBs levels can be measured to determine if vaccination is needed, or following a vaccination regimen, to determine if protective immunity has been achieved.
- Anti-HBs usually can be detected several weeks to several months after HBsAg is no longer found, and it may persist for many years or for life after acute infection has been resolved.
- It may disappear in some patients, with only antibody to core remaining.
- People with this antibody are not overtly infectious.
- Presence of the antibody without the presence of the antigen is evidence for immunity from reinfection, with virus of the same subtype.
What is the Hepatitis B virus?
Hepatitis B virus (HBV) infection, also known as serum hepatitis, is endemic throughout the world. The infection is spread primarily through blood transfusion or percutaneous contact with infected blood products, such as sharing of needles among injection drug users. The virus is also found in virtually every type of human body fluid and has been known to be spread through oral and genital contact. HBV can be transmitted from mother to child during delivery through contact with blood and vaginal secretions, but it is not commonly transmitted via the transplacental route.
The incubation period for HBV infection averages 60 to 90 days (range of 45 - 180 days).
What are common symptoms?
Common symptoms include:
- malaise,
- fever,
- gastroenteritis,
- and jaundice (icterus).
After acute infection, HBV infection becomes chronic in 30% to 90% of infected children younger than 5 years of age and in 5% to 10% of infected individuals age 5 or older. Some of these chronic carriers are asymptomatic, while others progress to chronic liver disease, including cirrhosis and hepatocellular carcinoma.
When you are exposed to hepatitis B, your body mounts an immune reaction against it as an invader. This happens whether you are exposed due to blood or sexual contact or if you are vaccinated with the hepatitis B vaccine.
Notes:
- Presence of anti-HBs is not an absolute indicator of resolved hepatitis infection, nor of protection from future infection. Since there are different serologic subtypes of hepatitis B virus, it is possible (and has been reported) for a patient to have antibody to one surface antigen type and to be acutely infected with virus of a different subtype. Thus, a patient may have coexisting HBsAg and anti-HBs. Transfused individuals or hemophiliacs receiving plasma components may give false-positive tests for antibody to hepatitis B surface antigen.
- Individuals who have received blood component therapies (eg, whole blood), plasma, or intravenous immunoglobulin infusion) in the previous 3 to 6 months may have false-positive hepatitis B surface antibody (anti-HBs) results due to passive transfer of anti-HBs present in these products.
Understand and improve your laboratory results with our health dashboard.
Upload your lab reports and get interpretation today.
Our technology helps to understand, combine, track, organize, and act on your medical lab test results.
>= 10 mIU/mL is considered reactive for antibodies against Heptitis B surface antigen.
The presence of anti-HBs is generally interpreted as indicating recovery and immunity from hepatitis B virus infection.
Anti-HBs also develops in a person who has been successfully vaccinated against hepatitis B. Among vaccine responders who completed a vaccine series, anti-HBs levels can decline over time, however the majority are still immune and will mount a response when exposed to HBV.
Interpret Your Lab Results
Upload your lab report and we’ll interpret and provide you with recomendations today.
Get StartedGet Started With Our Personal Plan
Advanced Plan
Unlimited Plan
Are You a Health Professional?
Get started with our professional plan
Welcome to Healthmatters Pro.
Save time on interpreting lab results with the largest database of biomarkers online. In-depth research on any test at your fingertips, all stored and tracked in one place. Learn more
Pro Plan
for health professionals
$45 per month
At HealthMatters, we're committed to maintaining the security and confidentiality of your personal information. We've put industry-leading security standards in place to help protect against the loss, misuse, or alteration of the information under our control. We use procedural, physical, and electronic security methods designed to prevent unauthorized people from getting access to this information. Our internal code of conduct adds additional privacy protection. All data is backed up multiple times a day and encrypted using SSL certificates. See our Privacy Policy for more details.
Beta-2 Microglobulin, Serum, HBsAg Screen, HCV RNA, Quantitative Real Time PCR, Hep A Ab, IgM, Hep B Core Ab, IgM, Hep B Core Ab, Tot, Hep C Virus Ab, Hepatitis A Virus Antibody, Hepatitis B Core Antibody (Total), Hepatitis B Surf Ab Quant, Hepatitis B Surface Antibody, Hepatitis B Surface Antibody, Qualitative, Hepatitis B Surface Antigen (HBsAg Screen), Hepatitis C Virus Antibody, HIV-1/HIV-2 Antibodies -EIA, Rapid plasma reagin (RPR), Treponema Palladium Total Antibodies (FTA abs), West Nile Virus AB (IgG), Serum